ProPhase Labs, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
ProPhase Labs, Inc. (PRPH) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 15.25 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-19
- ProPhase Labs, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 15.25M shares, a 2363.33% increase year-over-year.
- ProPhase Labs, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 12.46M shares, a 2181.32% increase year-over-year.
- ProPhase Labs, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 15.06M shares, a 225.41% increase year-over-year.
- ProPhase Labs, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 619.00K shares, a 86.63% decline year-over-year.
- ProPhase Labs, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 1.76M shares, a 291.33% increase from fiscal 2024.
- ProPhase Labs, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 450.00K shares, a 88.10% decline from fiscal 2023.
- ProPhase Labs, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 3.78M shares, a 208.73% increase from fiscal 2022.
- ProPhase Labs, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 1.23M shares, a 4.52% decline from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 15.25M shares 10-Q · filed 2026-08-19 | 15.25M shares 10-Q · filed 2026-08-19 | ||||||
| 2026-03-31 | 12.46M shares 10-Q/A · filed 2026-07-09 | |||||||
| 2025-12-31 | 1.76M shares 10-K · filed 2026-06-01 | |||||||
| 2025-09-30 | 15.06M shares 10-Q · filed 2025-11-19 | 15.06M shares 10-Q · filed 2025-11-19 | ||||||
| 2025-06-30 | 619.00K shares 10-Q · filed 2026-08-19 | 6.19M shares 10-Q · filed 2025-08-13 | 619.00K shares 10-Q · filed 2026-08-19 | 6.19M shares 10-Q · filed 2025-08-13 | ||||
| 2025-03-31 | 546.00K shares 10-Q/A · filed 2026-07-09 | 5.46M shares 10-Q · filed 2025-05-20 | ||||||
| 2024-12-31 | 450.00K shares 10-K · filed 2026-06-01 | 4.50M shares 10-K · filed 2025-04-01 | ||||||
| 2024-09-30 | 4.63M shares 10-Q · filed 2025-11-19 | 4.29M shares 10-Q · filed 2024-11-13 | 4.63M shares 10-Q · filed 2025-11-19 | 4.29M shares 10-Q · filed 2024-11-13 | ||||
| 2024-06-30 | 4.63M shares 10-Q · filed 2025-08-13 | 4.63M shares 10-Q · filed 2025-08-13 | ||||||
| 2024-03-31 | 4.83M shares 10-Q · filed 2025-05-20 | |||||||
| 2023-12-31 | 3.78M shares 10-K · filed 2025-04-01 | |||||||
| 2023-09-30 | 4.12M shares 10-Q · filed 2024-11-13 | 4.12M shares 10-Q · filed 2024-11-13 | ||||||
| 2023-06-30 | 4.92M shares 10-Q · filed 2024-08-14 | 4.92M shares 10-Q · filed 2024-08-14 | ||||||
| 2023-03-31 | 1.45M shares 10-Q · filed 2024-05-10 | |||||||
| 2022-12-31 | 1.23M shares 10-K · filed 2024-03-29 | |||||||
| 2022-09-30 | 825.00K shares 10-Q · filed 2023-11-13 | 1.06M shares 10-Q · filed 2023-11-13 | ||||||
| 2022-06-30 | 730.00K shares 10-Q · filed 2023-08-11 | 730.00K shares 10-Q · filed 2023-08-11 | ||||||
| 2022-03-31 | 1.26M shares 10-Q · filed 2023-05-12 | |||||||
| 2021-12-31 | 1.28M shares 10-K · filed 2023-03-29 | |||||||
| 2021-09-30 | 2.19M shares 10-Q · filed 2022-11-10 | 2.03M shares 10-Q · filed 2022-11-10 | ||||||
| 2021-06-30 | 5.28M shares 10-Q · filed 2022-08-12 | 5.28M shares 10-Q · filed 2022-08-12 | ||||||
| 2021-03-31 | 455.00K shares 10-Q · filed 2022-05-13 | |||||||
| 2020-12-31 | 5.25M shares 10-K · filed 2022-03-31 | |||||||
| 2017-09-30 | 504.17K shares 10-Q/A · filed 2018-08-20 | 456.73K shares 10-Q/A · filed 2018-08-20 | ||||||
| 2017-06-30 | 641.75K shares 10-Q/A · filed 2018-08-20 | 650.19K shares 10-Q/A · filed 2018-08-20 | ||||||
| 2017-03-31 | 689.91K shares 10-Q/A · filed 2018-08-20 | |||||||
| 2016-12-31 | 403.00K shares 10-K · filed 2017-02-24 | |||||||
| 2016-09-30 | 519.16K shares 10-Q/A · filed 2018-08-20 | 342.25K shares 10-Q/A · filed 2018-08-20 | ||||||
| 2016-06-30 | 276.17K shares 10-Q/A · filed 2018-08-20 | 244.11K shares 10-Q/A · filed 2018-08-20 | ||||||
| 2016-03-31 | 209.56K shares 10-Q/A · filed 2018-08-20 | |||||||
| 2015-12-31 | 420.50K shares 10-K · filed 2017-02-24 | |||||||
| 2015-09-30 | 375.25K shares 10-Q · filed 2016-11-14 | 335.45K shares 10-Q · filed 2016-11-14 | ||||||
| 2015-06-30 | 274.59K shares 10-Q · filed 2016-08-11 | 314.34K shares 10-Q · filed 2016-08-11 | ||||||
| 2015-03-31 | 358.41K shares 10-Q · filed 2016-05-13 | |||||||
| 2014-12-31 | 26.50K shares 10-K · filed 2017-02-24 | |||||||
| 2013-09-30 | 447.20K shares 10-Q · filed 2013-11-13 | 413.29K shares 10-Q · filed 2013-11-13 | ||||||
| 2013-06-30 | 359.27K shares 10-Q · filed 2013-08-13 | 401.85K shares 10-Q · filed 2013-08-13 | ||||||
| 2012-09-30 | 144.94K shares 10-Q · filed 2013-11-13 | 86.33K shares 10-Q · filed 2013-11-13 | ||||||
| 2012-06-30 | 20.96K shares 10-Q · filed 2013-08-13 | 56.36K shares 10-Q · filed 2013-08-13 | ||||||
| 2012-03-31 | 90.72K shares 10-Q · filed 2013-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |